Alpha Tau Medical (DRTS) Depreciation & Amortization (CF) (2021 - 2022)
Alpha Tau Medical's (DRTS) quarterly Depreciation & Amortization (CF) came in at $244000.0 in Q2 2022, up 5.63% quarter-over-quarter from $231000.0 in Q1 2022.
Alpha Tau Medical (DRTS) Depreciation & Amortization (CF) (2021 - 2022) Analysis & Trends
Alpha Tau Medical has disclosed Depreciation & Amortization (CF) across 2 years of filings, most recently posting $244000.0 for Q2 2022.
- Depreciation & Amortization (CF) for Q2 2022 came in at $244000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $244000.0 (up 5.63% YoY), and the FY2025 annual result was $12000.0, down 14.29% from the prior year.
- Depreciation & Amortization (CF) came in at $244000.0 for Q2 2022 at Alpha Tau Medical, up from $231000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $244000.0 in Q2 2022 to a low of $164000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 429,663.65 |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 244,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Mar 31, 2021 | 164,000.00 |
| Mar 31, 2021 | 164,000.00 |